Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Beam Therapeutics (BEAM) Depreciation & Amortization (IS) (2024 - 2025)

Historic Depreciation & Amortization (IS) for Beam Therapeutics (BEAM) over the last 2 years, with Q3 2025 value amounting to $5.6 million.

  • Beam Therapeutics' Depreciation & Amortization (IS) rose 155.25% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.1 million, marking a year-over-year change of. This contributed to the annual value of $21.9 million for FY2024, which is 955.93% up from last year.
  • Per Beam Therapeutics' latest filing, its Depreciation & Amortization (IS) stood at $5.6 million for Q3 2025, which was up 155.25% from $5.5 million recorded in Q2 2025.
  • Beam Therapeutics' Depreciation & Amortization (IS)'s 5-year high stood at $5.6 million during Q2 2024, with a 5-year trough of $5.4 million in Q1 2024.